New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Cooling glioblastoma to room temperature extends survival in preclinical study

Cooling glioblastoma to room temperature extends survival in preclinical study

by Jenny Owen,Emory UniversityConceptual model of a translational device to deliver cytostatic hypothermia for GBM. Representative diagram of a patient with GBM implanted with an envisioned cyto
Oncology January 30,2024
Cooling glioblastoma to room temperature extends survival in preclinical study

Cooling glioblastoma to room temperature extends survival in preclinical study

by Jenny Owen,Emory UniversityConceptual model of a translational device to deliver cytostatic hypothermia for GBM. Representative diagram of a patient with GBM implanted with an envisioned cyto
Oncology January 30,2024
Research confirms unique danger of postpartum breast cancers

Research confirms unique danger of postpartum breast cancers

by Joe Rojas-Burke,Oregon Health & Science UniversitySites of Metastasis by Estrogen Receptor (ER) Status and Time Since Recent Childbirth Group. Analyses included a total of 1787 known meta
Oncology January 30,2024
Research confirms unique danger of postpartum breast cancers

Research confirms unique danger of postpartum breast cancers

by Joe Rojas-Burke,Oregon Health & Science UniversitySites of Metastasis by Estrogen Receptor (ER) Status and Time Since Recent Childbirth Group. Analyses included a total of 1787 known meta
Oncology January 30,2024
Researchers find superantigen mutant can trigger immune response in ovarian cancer cells

Researchers find superantigen mutant can trigger immune response in ovarian cancer cells

by Liu Jia,Chinese Academy of SciencesThe transwell co-culture models of transcriptome experiment. Credit:International Journal of Molecular Sciences(2023). DOI: 10.3390/ijms24141179
Oncology January 30,2024
Researchers find superantigen mutant can trigger immune response in ovarian cancer cells

Researchers find superantigen mutant can trigger immune response in ovarian cancer cells

by Liu Jia,Chinese Academy of SciencesThe transwell co-culture models of transcriptome experiment. Credit:International Journal of Molecular Sciences(2023). DOI: 10.3390/ijms24141179
Oncology January 30,2024
Team reveals specific mechanism for promoting cancer vulnerability to ferroptosis

Team reveals specific mechanism for promoting cancer vulnerability to ferroptosis

by Luisa Hoffmann,Helmholtz Association of German Research CentresCredit: Pixabay/CC0 Public DomainA research team at Helmholtz Munich has revealed a specific mechanism that is able to promote c
Oncology January 30,2024
Team reveals specific mechanism for promoting cancer vulnerability to ferroptosis

Team reveals specific mechanism for promoting cancer vulnerability to ferroptosis

by Luisa Hoffmann,Helmholtz Association of German Research CentresCredit: Pixabay/CC0 Public DomainA research team at Helmholtz Munich has revealed a specific mechanism that is able to promote c
Oncology January 30,2024
Researcher leads first in-human multiple myeloma study with over 90% response rate

Researcher leads first in-human multiple myeloma study with over 90% response rate

by Indiana University School of MedicineMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Indiana University Melvin and Bren
Oncology January 30,2024
Researcher leads first in-human multiple myeloma study with over 90% response rate

Researcher leads first in-human multiple myeloma study with over 90% response rate

by Indiana University School of MedicineMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Indiana University Melvin and Bren
Oncology January 30,2024
Researchers discover cancer hijacks a class of enzyme motif mutations to fuel tumorigenesis

Researchers discover cancer hijacks a class of enzyme motif mutations to fuel tumorigenesis

byUniversity of North Carolina at Chapel Hill School of MedicineCredit: Pixabay/CC0 Public DomainCancer spreads throughout the human body in cunning, almost militaristic, ways. For example, it c
Oncology January 30,2024
Researchers discover cancer hijacks a class of enzyme motif mutations to fuel tumorigenesis

Researchers discover cancer hijacks a class of enzyme motif mutations to fuel tumorigenesis

byUniversity of North Carolina at Chapel Hill School of MedicineCredit: Pixabay/CC0 Public DomainCancer spreads throughout the human body in cunning, almost militaristic, ways. For example, it c
Oncology January 30,2024
Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models

Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models

by University of Texas M. D. Anderson Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResearchers at The University of Texa
Oncology January 30,2024
Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models

Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models

by University of Texas M. D. Anderson Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResearchers at The University of Texa
Oncology January 30,2024
Study finds the mechanism used by metastatic cancer cells to infiltrate the liver

Study finds the mechanism used by metastatic cancer cells to infiltrate the liver

by ResearchSEAThe liver sinusoidal endothelial cells (LSECs, beige) surround a blood vessel containing a cancer cell (green). The cancer cell is able to induce the formation of intracellular gaps
Oncology January 30,2024
Study finds the mechanism used by metastatic cancer cells to infiltrate the liver

Study finds the mechanism used by metastatic cancer cells to infiltrate the liver

by ResearchSEAThe liver sinusoidal endothelial cells (LSECs, beige) surround a blood vessel containing a cancer cell (green). The cancer cell is able to induce the formation of intracellular gaps
Oncology January 30,2024
Research team reveals mechanisms at work in progression of pancreatic cysts to pancreatic cancer

Research team reveals mechanisms at work in progression of pancreatic cysts to pancreatic cancer

by University of California, San FranciscoPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstitutePancreatic cysts have gained substantial
Oncology January 30,2024
Research team reveals mechanisms at work in progression of pancreatic cysts to pancreatic cancer

Research team reveals mechanisms at work in progression of pancreatic cysts to pancreatic cancer

by University of California, San FranciscoPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstitutePancreatic cysts have gained substantial
Oncology January 30,2024
Fungal association with tumors may predict worse outcomes

Fungal association with tumors may predict worse outcomes

by Weill Cornell Medical CollegeColonies of Candida tropicalis. Credit: Jennifer Conrad and the Iliev labThe presence of some fungal species in tumors predicts—and may even help drive—worse cance
Oncology January 30,2024
Fungal association with tumors may predict worse outcomes

Fungal association with tumors may predict worse outcomes

by Weill Cornell Medical CollegeColonies of Candida tropicalis. Credit: Jennifer Conrad and the Iliev labThe presence of some fungal species in tumors predicts—and may even help drive—worse cance
Oncology January 30,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com